| 臺大學術典藏 |
2022-09-09T04:21:16Z |
Hepatitis C Virus Reinfection in People With HIV in Taiwan After Achieving Sustained Virologic Response With Antiviral Treatment: The RECUR Study
|
Liu C.-H.; Sun H.-Y.; Peng C.-Y.; Hsieh S.-M.; Yang S.-S.; Kao W.-Y.; Shih Y.-L.; Lin C.-L.; Liu C.-J.; Sheng W.-H.; Lo Y.-C.; Liu W.-C.; Wu J.-H.; Su T.-H.; Tseng T.-C.; Chen P.-J.; Hung C.-C.; JIA-HORNG KAO |
| 臺大學術典藏 |
2022-09-06T02:42:36Z |
Genetic variation-optimized treatment benefit of angiotensin-converting enzyme inhibitors in patients with stable coronary artery disease: A 12-year follow-up study
|
Lee J.-K.; Wu C.-K.; Tsai C.-T.; LIAN-YU LIN; Lin J.-W.; Chien K.-L.; Hwang J.-J.; Lin C.-L.; Tseng C.-D.; Chiang F.-T. |
| 臺大學術典藏 |
2022-09-06T02:42:36Z |
Renin-angiotensin system genes polymorphisms and long-term prognosis in taiwanese patients with hypertension and coronary artery disease
|
Wu C.-K.; Lee J.K.; LIAN-YU LIN; Huang Y.-T.; Hwang J.J.; Lin C.-L.; Tseng C.-D.; Chiang F.-T. |
| 臺大學術典藏 |
2022-08-19T00:20:39Z |
Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
|
Local ablation group, Surveillance group, Diagnosis group, Staging group, Surgery group, TACE/TARE/HAI group, Target therapy/systemic therapy group, Radiotherapy group, Prevention group, Drafting group; Ni Y.-H.; Lin C.-L.; Hsu Y.-C.; Hsu C.-W.; Wu C.-Y.; Wu J.-C.; Cheng J.C.-H.; Leung S.W.; Chen S.-W.; Hsu H.-C.; Hong J.-H.; Wang P.-M.; Wang P.-M.; Ting C.-T.; Lee W.-C.; Chau G.-Y.; Wang C.-C.; Lee K.-T.; Huang Y.-H.; Ho M.-C.; Lin S.-M.; Huang G.-T.; Chen K.-Y.; Lin X.-Z.; Hwang J.-I.; Chiou Y.-Y.; Wang C.-K.; Hu J.-T.; Chen S.-C.; Liang P.-C.; Lee R.-C.; Wu D.-K.; Lin C.-Y.; Lin C.-C.; Cheng A.-L.; CHIUN HSU; Chao Y.; Chen L.-T.; Lee P.-H.; Liao L.-Y.; Huo T.-I.; Wu C.-C.; Hung C.-F.; Huang S.-F.; Yang S.-S.; Chen R.-C.; Chen C.-H.; Dai C.-Y.; Wang T.-E.; Su C.-W.; Wang J.-H.; Lu S.-N. |
| 臺大學術典藏 |
2022-08-09T03:50:15Z |
Nanoscale redox mapping at the MoS2-liquid interface
|
Du H.-Y.; Huang Y.-F.; Wong D.; Tseng M.-F.; Lee Y.-H.; Wang C.-H.; Lin C.-L.; Hoffmann G.; Chen K.-H.; Chen L.-C.; Du H.-Y.; Huang Y.-F.; Wong D.; Tseng M.-F.; Lee Y.-H.; Wang C.-H.; Lin C.-L.; Hoffmann G.; Chen K.-H.; Chen L.-C.; LI-CHYONG CHEN |
| 臺大學術典藏 |
2022-07-15T08:17:35Z |
Risk of skin cancer in patients with pterygium: A nationwide population-based cohort study in Taiwan
|
Yu H.-C.; Lin C.-L.; Chen Z.T.-Y.; FUNG-RONG HU; Sung F.-C.; Wang I.-J. |
| 臺大學術典藏 |
2022-07-15T06:43:38Z |
Hyperbaric oxygen treatment in Purtscher's retinopathy induced by chest injury
|
Lin Y.-C.; CHUNG-MAY YANG; Lin C.-L. |
| 臺大學術典藏 |
2022-07-15T06:43:08Z |
Diabetic retinopathy in patients with diabetic nephropathy: Development and progression
|
Jeng C.-J.; Hsieh Y.-T.; CHUNG-MAY YANG; Yang C.-H.; Lin C.-L.; Wang I.-J. |
| 臺大學術典藏 |
2022-07-15T06:43:02Z |
Development of diabetic retinopathy after cataract surgery
|
Jeng C.-J.; Hsieh Y.-T.; CHUNG-MAY YANG; Yang C.-H.; Lin C.-L.; Wang I.-J. |
| 臺大學術典藏 |
2022-07-15T06:43:02Z |
Diabetic Retinopathy in Patients with Dyslipidemia: Development and Progression
|
Jeng C.-J.; Hsieh Y.-T.; CHUNG-MAY YANG; Yang C.-H.; Lin C.-L.; Wang I.-J. |
| 臺大學術典藏 |
2022-07-14T07:25:42Z |
Diabetic retinopathy in patients with diabetic nephropathy: Development and progression
|
Jeng C.-J.; Hsieh Y.-T.; Yang C.-M.; CHANG-HAO YANG; Lin C.-L.; Wang I.-J. |
| 臺大學術典藏 |
2022-07-14T07:25:39Z |
Diabetic Retinopathy in Patients with Dyslipidemia: Development and Progression
|
Jeng C.-J.; Hsieh Y.-T.; Yang C.-M.; CHANG-HAO YANG; Lin C.-L.; Wang I.-J. |
| 臺大學術典藏 |
2022-07-14T07:25:38Z |
Development of diabetic retinopathy after cataract surgery
|
Jeng C.-J.; Hsieh Y.-T.; Yang C.-M.; CHANG-HAO YANG; Lin C.-L.; Wang I.-J. |
| 臺大學術典藏 |
2022-06-30T02:06:07Z |
Defect Engineering in Ambipolar Layered Materials for Mode-Regulable Nociceptor
|
Li M.; Yang F.-S.; Hsu H.-C.; Chen W.-H.; Kuo C.N.; Chen J.-Y.; Yang S.-H.; Yang T.-H.; Lin C.-Y.; Chou Y.; Lee M.-P.; Chang Y.-M.; Yang Y.-C.; Lee K.-C.; Chou Y.-C.; Lien C.-H.; Lin C.-L.; Chiu Y.-P.; Lue C.S.; Lin S.-P.; Lin Y.-F.; Li M.; Chou Y.-C.; YI-CHIA CHOU |
| 臺大學術典藏 |
2022-05-24T06:26:38Z |
The development of a low cost digital spinneret inspection system
|
Chen C.-J.;Jywe W.;Hung M.-W.;Lin C.-L.;Hung J.;Lin T.; Chen C.-J.; Jywe W.; Hung M.-W.; Lin C.-L.; Hung J.; Lin T.; Wen-Yuh Jywe |
| 臺大學術典藏 |
2022-05-24T06:14:14Z |
Calculation of osteonecrotic volume using two-dimensional projections: Comparison between the current volumetric measurement methods
|
Kuo C.-H.;Lin C.-L.;Ueng S.W.N.;Wang C.-J.;Lee M.S.; Kuo C.-H.; Lin C.-L.; Ueng S.W.N.; Wang C.-J.; Lee M.S.; CHUNG-HSIEN KUO |
| 臺大學術典藏 |
2022-05-09T08:46:30Z |
Vegetarian diet, food substitution, and nonalcoholic fatty liver
|
Chiu T.H.; Lin M.-N.; Pan W.-H.; YEN-CHING CHEN; Lin C.-L. |
| 臺大學術典藏 |
2022-05-03T06:19:26Z |
Differences in oral habit and lymphocyte subpopulation affect malignant transformation of patients with oral precancer
|
Yeh C.-Y.; Lin C.-L.; Chang M.-C.; Chen H.-M.; Kok S.-H.; SHU-HUI CHANG; Kuo Y.-S.; Hahn L.-J.; Chan C.-P.; Lee J.-J.; Jeng J.-H. |
| 臺大學術典藏 |
2022-04-29T08:09:58Z |
Androgen receptor exon 1 CAG repeat length and risk of hepatocellular carcinoma in women
|
MING-WHEI YU; Yang Y.-C.; Yang S.-Y.; Chang H.-C.; Liaw Y.-F.; Lin S.-M.; Liu C.-J.; Lee S.-D.; Lin C.-L.; Chen P.-J.; Lin S.-C.; Chen C.-J. |
| 臺大學術典藏 |
2022-04-29T08:09:58Z |
Increased risk for hepatitis B-related liver cirrhosis in relatives of patients with hepatocellular carcinoma in northern Taiwan
|
MING-WHEI YU; Chang H.-C.; Chen P.-J.; Liu C.-J.; Liaw Y.-F.; Lin S.-M.; Lee S.-D.; Lin S.-C.; Lin C.-L.; Chen C.-J. |
| 臺大學術典藏 |
2022-04-29T08:09:57Z |
Polymorphisms in XRCC1 and glutathione S-transferase genes and hepatitis B-related hepatocellular carcinoma
|
MING-WHEI YU; Yang S.-Y.; Pan I.-J.; Lin C.-L.; Liu C.-J.; Liaw Y.-F.; Lin S.-M.; Chen P.-J.; Lee S.-D.; Chen C.-J. |
| 臺大學術典藏 |
2022-04-29T08:09:57Z |
Association of cytokine and DNA repair gene polymorphisms with hepatitis B-related hepatocellular carcinoma
|
Chen C.-C.; Yang S.-Y.; Liu C.-J.; Lin C.-L.; Liaw Y.-F.; Lin S.-M.; Lee S.-D.; Chen P.-J.; Chen C.-J.; MING-WHEI YU |
| 臺大學術典藏 |
2022-04-29T08:09:57Z |
Role of Reproductive Factors in Hepatocellular Carcinoma: Impact on Hepatitis B- and C-Related Risk
|
MING-WHEI YU; Chang H.-C.; Chang S.-C.; Liaw Y.-F.; Lin S.-M.; Liu C.-J.; Lee S.-D.; Lin C.-L.; Chen P.-J.; Lin S.-C.; Chen C.-J. |
| 臺大學術典藏 |
2022-04-29T08:09:56Z |
Localization of a susceptibility locus for hepatocellular carcinoma to chromosome 4q in a hepatitis B hyperendemic area
|
Shih W.-L.; MING-WHEI YU; Chen P.-J.; Yeh S.-H.; Lo M.-T.; Chang H.-C.; Liaw Y.-F.; Lin S.-M.; Liu C.-J.; Lee S.-D.; Lin C.-L.; Hsiao C.K.; Yang S.-Y.; Chen C.-J. |
| 臺大學術典藏 |
2022-04-29T08:09:56Z |
Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: A prospective study in men
|
MING-WHEI YU; Yeh S.-H.; Chen P.-J.; Liaw Y.-F.; Lin C.-L.; Liu C.-J.; Shih W.-L.; Kao J.-H.; Chen D.-S.; Chen C.-J. |
| 臺大學術典藏 |
2022-04-29T08:09:55Z |
Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma
|
Chou Y.-C.; MING-WHEI YU; Wu C.-F.; Yang S.-Y.; Lin C.-L.; Liu C.-J.; Shin W.-L.; Chen P.-J.; Liaw Y.-F.; Chen C.-J. |
| 臺大學術典藏 |
2022-04-29T08:09:55Z |
Hepatitis B viral factors in HBeAg-negative carriers with persistently normal serum alanine aminotransferase levels
|
Lin C.-L.; Liao L.-Y.; Liu C.-J.; MING-WHEI YU; Chen P.-J.; Lai M.-Y.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-04-29T08:09:54Z |
Body-mass index and progression of hepatitis B: A population-based cohort study in men
|
MING-WHEI YU; Shih W.-L.; Lin C.-L.; Liu C.-J.; Jian J.-W.; Tsai K.-S.; Chen C.-J. |
| 臺大學術典藏 |
2022-04-29T08:09:54Z |
Long-term tracking of hepatitis B viral load and the relationship with risk for hepatocellular carcinoma in men
|
Wu C.-F.; MING-WHEI YU; Lin C.-L.; Liu C.-J.; Shih W.-L.; Tsai K.-S.; Chen C.-J. |
| 臺大學術典藏 |
2022-04-29T08:09:53Z |
Hepatitis B viraemia: Its heritability and association with common genetic variation in the interferon γ signalling pathway
|
Huang H.-H.; Shih W.-L.; Li Y.-H.; Wu C.-F.; Chen P.-J.; Lin C.-L.; Liu C.-J.; Liaw Y.-F.; Lin S.-M.; Lee S.-D.; MING-WHEI YU |
| 臺大學術典藏 |
2022-04-29T08:09:53Z |
Evidence for association with hepatocellular carcinoma at the PAPSS1 locus on chromosome 4q25 in a family-based study
|
Shih W.-L.; MING-WHEI YU; Chen P.-J.; Wu T.-W.; Lin C.-L.; Liu C.-J.; Lin S.-M.; Tai D.-I.; Lee S.-D.; Liaw Y.-F. |
| 臺大學術典藏 |
2022-04-29T08:09:53Z |
Insulin, glucose and hepatocellular carcinoma risk in male hepatitis B carriers: Results from 17-year follow-up of a population-based cohort
|
Chao L.-T.; Wu C.-F.; Sung F.-Y.; Lin C.-L.; Liu C.-J.; Huang C.-J.; Tsai K.-S.; MING-WHEI YU |
| 臺大學術典藏 |
2022-04-29T08:09:51Z |
Impact of Genetic Heterogeneity in Polymerase of Hepatitis B Virus on Dynamics of Viral Load and Hepatitis B Progression
|
Huang C.-J.; Wu C.-F.; Lan C.-Y.; Sung F.-Y.; Lin C.-L.; Liu C.-J.; Liu H.-F.; MING-WHEI YU |
| 臺大學術典藏 |
2022-04-29T08:09:51Z |
Influences of tobacco and alcohol use on hepatocellular carcinoma survival
|
Shih W.-L.; Chang H.-C.; Liaw Y.-F.; Lin S.-M.; Lee S.-D.; Chen P.-J.; Liu C.-J.; Lin C.-L.; MING-WHEI YU |
| 臺大學術典藏 |
2022-04-29T08:09:51Z |
Identification of a liver cirrhosis signature in plasma for predicting hepatocellular carcinoma risk in a population-based cohort of hepatitis B carriers
|
Liu C.-C.; Wang Y.-H.; Chuang E.Y.; Tsai M.-H.; Chuang Y.-H.; Lin C.-L.; Liu C.-J.; Hsiao B.-Y.; Lin S.-M.; Liu L.-Y.; MING-WHEI YU |
| 臺大學術典藏 |
2022-04-29T08:09:50Z |
Genome-wide identification of blood DNA methylation patterns associated with early-onset hepatocellular carcinoma development in hepatitis B carriers
|
Kao W.-Y.; Yang S.-H.; Liu W.-J.; Yeh M.-Y.; Lin C.-L.; Liu C.-J.; Huang C.-J.; Lin S.-M.; Lee S.-D.; Chen P.-J.; MING-WHEI YU |
| 臺大學術典藏 |
2022-04-29T08:09:50Z |
Circulating programmed death-1 as a marker for sustained high hepatitis b viral load and risk of hepatocellular carcinoma e95870
|
Cheng H.-Y.; Kang P.-J.; Chuang Y.-H.; Wang Y.-H.; Jan M.-C.; Wu C.-F.; Lin C.-L.; Liu C.-J.; Liaw Y.-F.; Lin S.-M.; Chen P.-J.; Lee S.-D.; MING-WHEI YU |
| 臺大學術典藏 |
2022-04-29T08:09:50Z |
Progressive accumulation of mutations in the hepatitis B virus genome and its impact on time to diagnosis of hepatocellular carcinoma
|
Sung F.-Y.; Lan C.-Y.; Huang C.-J.; Lin C.-L.; Liu C.-J.; Chen P.; Lin S.-M.; MING-WHEI YU |
| 臺大學術典藏 |
2022-04-29T08:09:50Z |
Development of risk scoring system for stratifying population for hepatocellular carcinoma screening
|
Hung Y.-C.; Lin C.-L.; Liu C.-J.; Hung H.; Lin S.-M.; Lee S.-D.; Chen P.-J.; Chuang S.-C.; MING-WHEI YU |
| 臺大學術典藏 |
2022-04-29T08:09:49Z |
Smoking and Hepatitis B Virus-VRelated Hepatocellular Carcinoma Risk: The Mediating Roles of Viral Load and Alanine Aminotransferase
|
Wang Y.-H.; Chuang Y.-H.; Wu C.-F.; Jan M.-C.; Wu W.-J.; Lin C.-L.; Liu C.-J.; Yang Y.-C.; Chen P.-J.; Lin S.-M.; Tsai M.-H.; Huang Y.-W.; MING-WHEI YU |
| 臺大學術典藏 |
2022-04-29T08:09:49Z |
Influence of Metabolic Risk Factors on Risk of Hepatocellular Carcinoma and Liver-Related Death in Men With Chronic Hepatitis B: A Large Cohort Study
|
MING-WHEI YU; Lin C.-L.; Liu C.-J.; Yang S.-H.; Tseng Y.-L.; Wu C.-F. |
| 臺大學術典藏 |
2022-04-29T08:09:48Z |
Longitudinal change of metabolite profile and its relation to multiple risk factors for the risk of developing hepatitis B-related hepatocellular carcinoma
|
Huang B.-Y.; Tsai M.-R.; Hsu J.-K.; Lin C.-Y.; Lin C.-L.; Hu J.-T.; Huang Y.-W.; Liu C.-J.; Wu W.-J.; Wu C.-F.; Sung F.-Y.; Chen P.-J.; Liang H.-J.; Lin S.-M.; MING-WHEI YU |
| 臺大學術典藏 |
2022-04-29T08:09:48Z |
Hepatic steatosis and development of type 2 diabetes: Impact of chronic hepatitis B and viral specific factors
|
MING-WHEI YU; Lin C.-L.; Liu C.-J.; Huang Y.-W.; Hu J.-T.; Wu W.-J.; Wu C.-F. |
| 臺大學術典藏 |
2022-04-29T03:54:02Z |
Development of risk scoring system for stratifying population for hepatocellular carcinoma screening
|
Hung Y.-C.; Lin C.-L.; Liu C.-J.; Hung Hung; Lin S.-M.; Lee S.-D.; Chen P.-J.; Chuang S.-C.; Yu M.-W. |
| 臺大學術典藏 |
2022-04-28T12:31:59Z |
Genetic variation-optimized treatment benefit of angiotensin-converting enzyme inhibitors in patients with stable coronary artery disease: A 12-year follow-up study
|
Lee J.-K.; Wu C.-K.; Tsai C.-T.; Lin L.-Y.; Lin J.-W.; KUO-LIONG CHIEN; Hwang J.-J.; Lin C.-L.; Tseng C.-D.; Chiang F.-T. |
| 臺大學術典藏 |
2022-04-26T07:24:41Z |
Pregnancy outcome after I-131 therapy for patients with thyroid cancer a nationwide population-based cohort study
|
KUAN-YIN KO; Yen R.-F.; Lin C.-L.; Cheng M.-F.; Huang W.-S.; Kao C.-H. |
| 臺大學術典藏 |
2022-04-26T07:24:41Z |
131I treatment for thyroid cancer and the risk of developing salivary and lacrimal gland dysfunction and a second primary malignancy: a nationwide population-based cohort study
|
KUAN-YIN KO; Kao C.-H.; Lin C.-L.; Huang W.-S.; Yen R.-F. |
| 臺大學術典藏 |
2022-04-26T07:24:38Z |
Impact of initial myocardial perfusion imaging versus invasive coronary angiography on outcomes in coronary artery disease: a nationwide cohort study
|
Hung G.-U.; KUAN-YIN KO; Lin C.-L.; Yen R.-F.; Kao C.-H. |
| 臺大學術典藏 |
2022-04-25T06:39:05Z |
Harnessing the Inductive Effect to Design New Donor-Acceptor-Acceptor′-Configured Small-Molecule Donors for Vacuum-Processed Organic Photovoltaics
|
Chen C.-H;Chen C.-J;Chen Y.-A;Chang Y.-H;Liu H.-C;Lo Y.-C;Lin B.-Y;Lin C.-L;Easley C.J;Bardeen C.J;Chen Y.-S;Lee J.-H;Chiu T.-L;Wong K.-T.; Chen C.-H; Chen C.-J; Chen Y.-A; Chang Y.-H; Liu H.-C; Lo Y.-C; Lin B.-Y; Lin C.-L; Easley C.J; Bardeen C.J; Chen Y.-S; Lee J.-H; Chiu T.-L; Wong K.-T.; KEN-TSUNG WONG |
| 臺大學術典藏 |
2022-04-21T06:51:13Z |
Cost-effectiveness analysis of triple test in second-trimester maternal serum screening for Down's syndrome: An experience from Taiwan with decreasing birth rate but increasing population of old pregnant women
|
Hwa H.-L.; Yen M.-F.; Lin C.-L.; Ko T.-M.; Hsieh F.-J.; Chen, Tony Hsiu Hsi |
